Intco Medical Soars to Day High with 4.83% Intraday Surge

Intco Medical Technology Co., Ltd. has experienced a significant uptick in its stock performance, gaining 4.83% on June 29, 2026. The stock reached an intraday high of CNY 40.36, reflecting a strong day of trading compared to the broader market, as the China Shanghai Composite index only rose by 1.16% on the same day. Over the past week, Intco Medical has shown a positive trend with a 3.37% increase, contrasting sharply with the Shanghai Composite's decline of 2.14%. However, the stock's performance over the past month has been less favorable, down 7.57%, despite a remarkable year-to-date gain of 3.24%. Notably, the company has achieved a substantial 70.6% increase over the past year, significantly outperforming the Shanghai Composite's 18.97%. Despite these gains, Intco Medical faces challenges, including a notable decline in net profit and a high debt-equity ratio. The company's market capitalization stands at CNY 21,666 million, and it currently has a price-to-earnings ratio of 39.00, indicating a premium valuation in the pharmaceuticals and biotechnology sector.